Q3 2024 · 13F-HR
Column Group LLCholdings as filed
Filed 2024-11-14 · accession 0000950123-24-011839
$69.6M
Reported value
6
Positions
2024-09-30
Period end
The Brief · Column Group LLC · Q3 2024
AI · grounded in 13F
Column Group LLC reported no changes to its 13F holdings for 2024-09-30 relative to 2024-06-30.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 68622P109 | ORIC | ORIC Pharmaceuticals Inc. | $36.3M | 52.2% | 3,540,777 | Common | SOLE |
| 87990A106 | TNYA | Tenaya Therapeutics, Inc. | $18.1M | 26.1% | 9,400,290 | Common | SOLE |
| 86889P109 | — | Surrozen, Inc. | $9.7M | 13.9% | 810,088 | Common | SOLE |
| 75382E109 | — | RAPT Therapeutics Inc | $5.4M | 7.74% | 2,680,621 | Common | SOLE |
| 786700104 | SGMT | Sagimet Biosciences Inc. | $47,558 | 0.07% | 17,169 | Common | SOLE |
| 76155X100 | RVMD | Revolution Medicines Inc | $2,086 | 0.00% | 46 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.